Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2026-05-21 @ 11:43 AM
Study NCT ID:
NCT04922658
Status:
RECRUITING
Last Update Posted:
2024-07-31
First Post:
2021-06-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer
Sponsor:
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HMPL-012-SPRING-L106
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None